Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 63

1.

A new model to predict remission status in AML patients based on day 14 bone marrow biopsy.

Norkin M, Chang M, An Q, Leather H, Katragadda L, Li Y, Moreb JS, May WS, Brown RA, Hsu JW, Hiemenz JW, Wingard JR, Cogle CR.

Leuk Res. 2016 Apr 20;46:69-73. doi: 10.1016/j.leukres.2016.04.013. [Epub ahead of print]

PMID:
27132034
2.

Ex vivo virotherapy with myxoma virus does not impair hematopoietic stem and progenitor cells.

Villa NY, Bais S, Chan WM, Meacham AM, Wise E, Rahman MM, Moreb JS, Rosenau EH, Wingard JR, McFadden G, Cogle CR.

Cytotherapy. 2016 Mar;18(3):465-80. doi: 10.1016/j.jcyt.2015.12.007.

PMID:
26857235
3.

Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research Study.

D'Souza A, Dispenzieri A, Wirk B, Zhang MJ, Huang J, Gertz MA, Kyle RA, Kumar S, Comenzo RL, Peter Gale R, Lazarus HM, Savani BN, Cornell RF, Weiss BM, Vogl DT, Freytes CO, Scott EC, Landau HJ, Moreb JS, Costa LJ, Ramanathan M, Callander NS, Kamble RT, Olsson RF, Ganguly S, Nishihori T, Kindwall-Keller TL, Wood WA, Mark TM, Hari P.

J Clin Oncol. 2015 Nov 10;33(32):3741-9. doi: 10.1200/JCO.2015.62.4015. Epub 2015 Sep 14.

PMID:
26371138
4.

Osteonecrosis of the Jaw in the United States Food and Drug Administration's Adverse Event Reporting System (FAERS).

Zhang X, Hamadeh IS, Song S, Katz J, Moreb JS, Langaee TY, Lesko LJ, Gong Y.

J Bone Miner Res. 2016 Feb;31(2):336-40. doi: 10.1002/jbmr.2693. Epub 2015 Sep 4.

PMID:
26288087
5.

Immunotherapy for multiple myeloma: Current status and future directions.

Ayed AO, Chang LJ, Moreb JS.

Crit Rev Oncol Hematol. 2015 Dec;96(3):399-412. doi: 10.1016/j.critrevonc.2015.06.006. Epub 2015 Jun 28. Review.

PMID:
26153389
6.

New primary malignancy masquerading as metastatic prostate adenocarcinoma.

Szwed EA, Sliesoraitis S, Nguyen TC, Nguyen MN, Moreb JS, Zlotecki RA, Crispen PL, Dang NH, Dang LH.

Case Rep Oncol Med. 2015;2015:358572. doi: 10.1155/2015/358572. Epub 2015 Feb 19.

7.

New cancers after autotransplantations for multiple myeloma.

Mahindra A, Raval G, Mehta P, Brazauskas R, Zhang MJ, Zhong X, Bird JM, Freytes CO, Hale GA, Herzig R, Holmberg LA, Kamble RT, Kumar S, Lazarus HM, Majhail NS, Marks DI, Moreb JS, Olsson R, Saber W, Savani BN, Schiller GJ, Tay J, Vogl DT, Waller EK, Wiernik PH, Wirk B, Lonial S, Krishnan AY, Dispenzieri A, Brandenburg NA, Gale RP, Hari PN.

Biol Blood Marrow Transplant. 2015 Apr;21(4):738-45. doi: 10.1016/j.bbmt.2014.12.028. Epub 2014 Dec 31.

8.

Aldehyde dehydrogenases in cancer: an opportunity for biomarker and drug development?

Pors K, Moreb JS.

Drug Discov Today. 2014 Dec;19(12):1953-63. doi: 10.1016/j.drudis.2014.09.009. Epub 2014 Sep 26. Review.

PMID:
25256776
9.

Tandem Autologous Stem Cell Transplantation for Multiple Myeloma Patients Based on Response to Their First Transplant-A Prospective Phase II Study.

Byrne M, Salmasinia D, Leather H, Cogle CR, Davis A, Hsu JW, Wiggins L, Chang MN, An Q, Wingard JR, Moreb JS.

Clin Med Insights Oncol. 2014 Sep 3;8:101-5. doi: 10.4137/CMO.S16835. eCollection 2014.

10.

Oral squamous cell carcinoma positive for p16/human papilloma virus in post allogeneic stem cell transplantation: 2 cases and review of the literature.

Katz J, Islam MN, Bhattacharyya I, Sandow P, Moreb JS.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2014 Sep;118(3):e74-8. doi: 10.1016/j.oooo.2014.05.025. Epub 2014 Jun 13. Review.

11.

Multiple myeloma in bisphosphonate-affected jaws--a diagnostic challenge: case report.

Katkar RA, Katz J, Moreb JS, Nair MK.

Quintessence Int. 2014 Jul-Aug;45(7):613-7. doi: 10.3290/j.qi.a31962.

PMID:
24847501
12.

Continuous infusion cyclophosphamide and low-dose total body irradiation is a safe and effective conditioning regimen for autologous transplant in multiple myeloma.

Byrne M, Wingard JR, Moreb JS.

Transplant Proc. 2013 Nov;45(9):3361-5. doi: 10.1016/j.transproceed.2013.03.054.

PMID:
24182816
13.
14.

Myxoma and vaccinia viruses bind differentially to human leukocytes.

Chan WM, Bartee EC, Moreb JS, Dower K, Connor JH, McFadden G.

J Virol. 2013 Apr;87(8):4445-60. doi: 10.1128/JVI.03488-12. Epub 2013 Feb 6.

15.

Salvage second hematopoietic cell transplantation in myeloma.

Michaelis LC, Saad A, Zhong X, Le-Rademacher J, Freytes CO, Marks DI, Lazarus HM, Bird JM, Holmberg L, Kamble RT, Kumar S, Lill M, Meehan KR, Saber W, Schriber J, Tay J, Vogl DT, Wirk B, Savani BN, Gale RP, Vesole DH, Schiller GJ, Abidi M, Anderson KC, Nishihori T, Kalaycio ME, Vose JM, Moreb JS, Drobyski W, Munker R, Roy V, Ghobadi A, Holland HK, Nath R, To LB, Maiolino A, Kassim AA, Giralt SA, Landau H, Schouten HC, Maziarz RT, Mikhael J, Kindwall-Keller T, Stiff PJ, Gibson J, Lonial S, Krishnan A, Dispenzieri A, Hari P; Plasma Cell Disorders Working Committee of the Center for International Blood and Marrow Transplant Research.

Biol Blood Marrow Transplant. 2013 May;19(5):760-6. doi: 10.1016/j.bbmt.2013.01.004. Epub 2013 Jan 5.

16.

Regulation of in vitro human T cell development through interleukin-7 deprivation and anti-CD3 stimulation.

Patel ES, Okada S, Hachey K, Yang LJ, Durum SK, Moreb JS, Chang LJ.

BMC Immunol. 2012 Aug 16;13:46. doi: 10.1186/1471-2172-13-46.

17.

Lenalidomide after stem-cell transplantation for multiple myeloma.

McCarthy PL, Owzar K, Hofmeister CC, Hurd DD, Hassoun H, Richardson PG, Giralt S, Stadtmauer EA, Weisdorf DJ, Vij R, Moreb JS, Callander NS, Van Besien K, Gentile T, Isola L, Maziarz RT, Gabriel DA, Bashey A, Landau H, Martin T, Qazilbash MH, Levitan D, McClune B, Schlossman R, Hars V, Postiglione J, Jiang C, Bennett E, Barry S, Bressler L, Kelly M, Seiler M, Rosenbaum C, Hari P, Pasquini MC, Horowitz MM, Shea TC, Devine SM, Anderson KC, Linker C.

N Engl J Med. 2012 May 10;366(19):1770-81. doi: 10.1056/NEJMoa1114083.

18.

Selective purging of human multiple myeloma cells from autologous stem cell transplantation grafts using oncolytic myxoma virus.

Bartee E, Chan WM, Moreb JS, Cogle CR, McFadden G.

Biol Blood Marrow Transplant. 2012 Oct;18(10):1540-51. doi: 10.1016/j.bbmt.2012.04.004. Epub 2012 Apr 16.

19.

Extramedullary disease in plasma cell myeloma: the iceberg phenomenon.

Wirk B, Wingard JR, Moreb JS.

Bone Marrow Transplant. 2013 Jan;48(1):10-8. doi: 10.1038/bmt.2012.26. Epub 2012 Mar 12. Review.

PMID:
22410751
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk